(Q71789809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

R. Murray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579495

20 May 2024

P. Pitt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579495

20 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7579495

20 May 2024

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://link.springer.com/content/pdf/10.1007/BF00665976.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/BF00665976

http://link.springer.com/article/10.1007/BF00665976/fulltext.html

20 May 2024

1 reference

https://api.crossref.org/works/10.1007/BF00665976

http://link.springer.com/content/pdf/10.1007/BF00665976

20 May 2024

1 reference

https://api.crossref.org/works/10.1007/BF00665976

Breast Cancer Research and Treatment

20 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

249-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00665976

21 October 2019

exact match

0 references

cites work

4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

1 reference

12 December 2020

Aromatase inhibitors: basic and clinical studies

1 reference

12 December 2020

Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.

1 reference

12 December 2020

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

1 reference

12 December 2020

Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study

1 reference

12 December 2020

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

1 reference

12 December 2020

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment

1 reference

12 December 2020

4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00665976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7579495%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference